The Association Between CBT-I Dose and Innate Immunity in Insomnia and Fatigue in Prostate Cancer Patients
Enrolling By Invitation
18 years - 99 years
All
Phase
N/A
20 participants needed
1 Location
Brief description of study
The research study is being conducted secondary and after your
completion of the primary study (Effect of Radiation Therapy on Sleepiness and
Activity in Prostate and Breast Cancer Patients). The purpose of the
current study is to assess the effectiveness of a behavioral treatment for
insomnia (also known as Cognitive Behavioral Therapy for Insomnia) on both
insomnia and cancer-related pre and post Radiation Therapy. Information from
the primary study will be used in conjunction with the data from this study to
see if there are changes in your sleepiness and fatigue. Information that will
be used includes study questionnaires, sleep study and FMRI data and blood draw
information.
Cognitive Behavioral Therapy for Insomnia (CBT-I) has been shown to be
an effective treatment for insomnia in both cancer and non-cancer populations.
However, CBT-I has yet to demonstrate an effect on cancer-related fatigue. This
study aims to see whether an increased amount of CBT-I sessions decreases the
amount of fatigue that you may be experiencing.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: prostate cancer,men's health
-
Age: 18 years - 99 years
-
Gender: All
Updated on
04 Aug 2024.
Study ID: 834620
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245
